These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3950273)

  • 41. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
    Elia J; Borcherding BG; Rapoport JL; Keysor CS
    Psychiatry Res; 1991 Feb; 36(2):141-55. PubMed ID: 2017529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methylphenidate: rate-dependent effects on hyperactivity.
    Rapport MD; DuPaul GJ
    Psychopharmacol Bull; 1986; 22(1):223-8. PubMed ID: 3523577
    [No Abstract]   [Full Text] [Related]  

  • 44. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
    Swanson J; Gupta S; Guinta D; Flynn D; Agler D; Lerner M; Williams L; Shoulson I; Wigal S
    Clin Pharmacol Ther; 1999 Sep; 66(3):295-305. PubMed ID: 10511066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Jafarinia M; Mohammadi MR; Modabbernia A; Ashrafi M; Khajavi D; Tabrizi M; Yadegari N; Akhondzadeh S
    Hum Psychopharmacol; 2012 Jul; 27(4):411-8. PubMed ID: 22806822
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance.
    Rapport MD; Quinn SO; DuPaul GJ; Quinn EP; Kelly KL
    J Abnorm Child Psychol; 1989 Dec; 17(6):669-89. PubMed ID: 2607058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.
    Kooij JJ; Burger H; Boonstra AM; Van der Linden PD; Kalma LE; Buitelaar JK
    Psychol Med; 2004 Aug; 34(6):973-82. PubMed ID: 15554568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder.
    Klorman R; Brumaghim JT; Fitzpatrick PA; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):702-9. PubMed ID: 2228922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The visual ERP predicts clinical response to methylphenidate in hyperactive children.
    Halliday R; Callaway E; Rosenthal JH
    Psychophysiology; 1984 Jan; 21(1):114-21. PubMed ID: 6366860
    [No Abstract]   [Full Text] [Related]  

  • 52. Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder.
    Ashare RL; Hawk LW; Shiels K; Rhodes JD; Pelham WE; Waxmonsky JG
    Psychophysiology; 2010 Sep; 47(5):838-45. PubMed ID: 20233343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity.
    Weizman A; Weitz R; Szekely GA; Tyano S; Belmaker RH
    J Am Acad Child Psychiatry; 1984 May; 23(3):295-8. PubMed ID: 6145738
    [No Abstract]   [Full Text] [Related]  

  • 54. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder.
    Schrantee A; Mutsaerts H; Bouziane C; Tamminga H; Bottelier MA; Reneman L
    Neuroimage Clin; 2017; 13():123-129. PubMed ID: 27942455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response to methylphenidate in boys with attention-deficit hyperactivity disorder.
    Zeiner P; Bryhn G; Bjercke C; Truyen K; Strand G
    Acta Paediatr; 1999 Mar; 88(3):298-303. PubMed ID: 10229041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder.
    Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexpected effects of methylphenidate in attention-deficit/hyperactivity disorder reflect decreases in core/secondary symptoms and physical complaints common to all children.
    Rapport MD; Kofler MJ; Coiro MM; Raiker JS; Sarver DE; Alderson RM
    J Child Adolesc Psychopharmacol; 2008 Jun; 18(3):237-47. PubMed ID: 18582178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of stimulant medication on academic performance, in the context of multimodal treatment, in attention deficit disorders with hyperactivity: two case reports.
    Schmidt K; Solanto MV; Sanchez-Kappraff M; Vargas P; Wein S
    J Clin Psychopharmacol; 1984 Apr; 4(2):100-3. PubMed ID: 6707235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD; Nolan E; Sprafkin J; Sverd J
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.